CYCLOSPORINE AND CALCIUM-CHANNEL BLOCKERS - AN EXPLOITABLE DRUG-INTERACTION

被引：11

作者：

LEIBBRANDT, DM ^{[1
]}

DAY, RO ^{[1
]}

机构：

[1] UNIV NEW S WALES,ST VINCENTS HOSP,SCH PHYSIOL & PHARMACOL,KENSINGTON,NSW 2033,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1992年 / 157卷 / 05期

关键词：

D O I：

10.5694/j.1326-5377.1992.tb137177.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：296 / 297

页数：2

共 25 条

[11] DO CALCIUM-CHANNEL BLOCKERS HAVE ANY INFLUENCE ON THE IMMUNOLOGICAL STATUS OF RENAL GRAFT RECIPIENTS ON CYCLOSPORINE THERAPY [J].

MANDREOLI, M ;

ESPOSTI, ED ;

COCCHI, R ;

FABBRI, A ;

GUERRINI, L ;

FUSAROLI, M .

AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (01) :58-60

[12]

MCCAULEY J, 1989, TRANSPLANT P, V21, P3955

[13]

MCEVOY GK, 1992, DRUG INFORMATION 199

[14] CALCIUM-CHANNEL BLOCKERS AND CYCLOSPORINE METABOLISM [J].

MCNALLY, P ;

MISTRY, N ;

IDLE, J ;

WALLS, J ;

FEEHALLY, J .

TRANSPLANTATION, 1989, 48 (06) :1071-1071

[15] CALCIUM-ANTAGONIST AGENTS AND THEIR CLINICAL USE .1. THE CALCIUM-ANTAGONIST DRUGS [J].

NAYLER, WG .

MEDICAL JOURNAL OF AUSTRALIA, 1988, 149 (11-12) :682-686

[16]

NEUMAYER HH, 1986, LANCET, V2, P523

[17] SHORT-TERM EFFECTS OF CALCIUM-ANTAGONISTS ON HEMODYNAMICS AND CYCLOSPORINE PHARMACOKINETICS IN HEART-TRANSPLANT AND KIDNEY-TRANSPLANT PATIENTS [J].

ROY, LF ;

EAST, DS ;

BROWNING, FM ;

SHAW, D ;

OGILVIE, RI ;

CARDELLA, C ;

LEENEN, FHH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (06) :657-667

[18]

RUSSELL JD, 1989, AM J MED, V87, P306

[19]

RYFFEL B, 1988, TRANSPL P, V20, P575

[20]

THOMAS J, 1992, PRESCRIPTION PRODUCT

← 1 2 3 →